WST 株価分析 — WEST PHARMACEUTICAL SERVICES INC (Healthcare >> Medical Instruments & Supplies)
WST に関するよくある質問
WSTのPER(株価収益率)は?
WEST PHARMACEUTICAL SERVICES INC(WST)は現在PER 42.31倍で取引されています。
WSTのROE(自己資本利益率)は?
WEST PHARMACEUTICAL SERVICES INCのROEは18.89%です。
WSTの配当利回りは?
WEST PHARMACEUTICAL SERVICES INCの配当利回りは0.26%です。
WSTの品質スコア(Quality Score)は?
当社のAIはWSTの総合財務品質を100点中69点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。
WSTは今が買い時ですか?
当社AIのタイミングスコアは100点中67点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。
WSTはどのセクターに属しますか?
WEST PHARMACEUTICAL SERVICES INCはHealthcare >> Medical Instruments & Suppliesセクターに分類されます(NYSE市場)
WST AI Analysis Summary
Our AI summary for WST: WEST PHARMACEUTICAL SERVICES INC (NYSE), Healthcare >> Medical Instruments & Supplies sector. The stock currently trades at a P/E of 42.31, ROE of 18.89%, a dividend yield of 0.26%. Its financial Quality Score stands at 69/100 — mid-range fundamentals relative to the market. The AI Timing Score is 67/100 — technical signals are mixed; watch for a clearer trend. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
|
USD 340.96
Price
1.37
(0.40%)
Day Change
|
|
|---|
WST, ファンダメンタルスコアはok ( ファンダメンタル = 69) そして テクニカルスコアは ...(Sign In to See)...
- Signal
- NEUTRAL
- Signal Description
- Company financial health is OK
- Reason
-
ROEの伸びが低い
昨年度のROEが一昨年比で低い
ROAの伸びが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
In details, quality factors are not good , financial health is not quite good , and ability to make profit is ok , ...
| Deepscope 分析 |
|
47% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 99 |
| Magic Formula Rank by ROA |
1481
|
| Magic Formula Rank by ROE |
1481
|
| Magic Formula Rank by ROIC |
1616
|
| Price | 340.96 |
| PBV / Sector |
7.99 / 3.37
|
| Earning Per Share | 8.06 |
| PE / Sector |
42.31 / 44.25
|
| PEG or PE/Growth / Sector |
-10.90 / -1.35
|
| Average 1M Daily Value |
254.81 M
GREAT
|
| Average 1W Daily Value |
272.44 M
GREAT
|
| Timing Factors |
|
42% |
| Financial Health |
|
58% |
| ポイントになる統計 |
|
64% |
| 配当 |
|
12% |
| 登録情報 |
| Analyze Date | 2026-08-01 08:00:42 |
| Symbol | WST |
| Name | WEST PHARMACEUTICAL SERVICES INC |
| Sector | Healthcare >> Medical Instruments & Supplies |
| Market | NYSE |
| Listed Shares | 70.38 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 23,898.90 / 16,159.14 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 530 Herman O. West Drive, Exton, PA, United States, 19341-1147
Phone: 610 594 2900
Website: https://www.westpharma.com
Employees: 10,800
Description: West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging products. This segment also provides drug containment solutions in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment primarily serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.
Analyst Ratings & Target Price
ME vs SECTOR Healthcare >> Medical Instruments & Supplies
Click a bubble to view stock details · Bubble size represents market capitalization share
Google